Hong Wu - Concepedia

Author

Hong Wu

University of Toronto

Also Known As

Heather Christofk, Hong WU, Hong Wu, Hong Wu (105254), Jian Chang, Jiangyan Cao, Meir Shaw, Rachael Stampfer, Wu, Hong

110

Publications

5.3K

Citations

H-Index

112

Concepts

All Affiliations

University of Toronto Structural Genomics Consortium Princess Margaret Cancer Centre Bristol-Myers Squibb (United States)Chinese Academy of Sciences

About

Hong Wu is an author at University of Toronto specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	34	2.3K
2	Natural Sciences	21	23	1.5K
3	Biochemistry	18	20	1.4K
4	Health Sciences	2	2	73
5	Engineering	1	1	133

Hong Wu

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia Florian Grebien, Masoud Vedadi, Matthäus Getlik, Nature Chemical Biology Hematological MalignancyMedicinePharmacologyCancer BiologyCell Biology	2015	282
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases Mohammad S. Eram, Yudao Shen, Magdalena M. Szewczyk, ACS Chemical Biology Drug TargetEpigenetic ChangeMolecular BiologyType Iii PrmtsChemical Biology	2015	280
Structural Biology of Human H3K9 Methyltransferases Hong Wu, Jinrong Min, V.V. Lunin, PLoS ONE	2010	260
Protein Profiling with Epstein-Barr Nuclear Antigen-1 Reveals an Interaction with the Herpesvirus-associated Ubiquitin-specific Protease HAUSP/USP7 Melissa N. Holowaty, Mahel Zeghouf, Hong Wu, Journal of Biological Chemistry	2003	225
( <i>R</i> )-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells Dalia Baršytė-Lovejoy, Fengling Li, Menno J. Oudhoff, Proceedings of the National Academy of Sciences	2014	188
Structural and Histone Binding Ability Characterizations of Human PWWP Domains Hong Wu, Hong Zeng, Robert Lam, PLoS ONE	2011	178
An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells Hideaki Tsutsui, Bahram Valamehr, Antreas Hindoyan, Nature Communications Regenerative MedicineInduced Pluripotent Stem CellLong-term MaintenanceMedicineAdult Stem Cell	2011	172
Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2 Weihong Zheng, Glorymar Ibáñez, Hong Wu, Journal of the American Chemical Society Biomolecular Structure PredictionMolecular RegulationEpigenetic ChangeMolecular BiologyChemical Biology	2012	145
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor Hyung-Gu Kim, Li Tan, Ellen Weisberg, ACS Chemical Biology Drug TargetMolecular BiologyCytoskeletonPharmacotherapySignaling Pathway	2013	144
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Kazuhide Nakayama, Magdalena M. Szewczyk, Carlo dela Seña, Oncotarget	2018	135

Page 1